Efficacy of Tramadol With Ropivacaine for Modified Pectoral Nerve Block in Breast Cancer Surgery

Comparison of Post Operative Analgesia Between 0.25% Ropivacaine and 0.25% Ropivacaine Combined With Tramadol in Ultrasound Guided Modified Pectoral Nerve Block for Patient Undergoing Modified Radical Mastectomy.

Status

Enrolling by invitation

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07775053

Enrollment

Registered

2026-08-20

Start date

2026-01-22

Completion date

2027-08-01

Last updated

2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

In this study the investigators will compare the post operative opoid consumption for patient undergoing modified radical mastectomy. The patients will be divided into two groups one group will receive modified pectoral nerve block with local anesthetic ropivacaine combined with tramadol and other group will receive pectoral nerve block with ropivacaine only

Interventions

PROCEDUREPectoral Nerve Block

One group will receive ropivacaine with tramadol in modified pectoral nerve block

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

1. Female Patients aged 20-70 years 2. Patients scheduled for elective unilateral modified radical mastectomy 3. Patients with ASAI andII physical status.

Exclusion criteria

1. Patients on anticoagulant therapy. 2. Patients with a BMI≥35 kg/m3. 3. Patients with a history of allergy to local anesthetics. 4. Patients with significant neurological or psychiatric disorders. 5. Pregnant patients.

Design outcomes

Primary

Measure	Time frame	Description
Postoperative Pain with visual analogue scale	24 hours postoperatively	Post operatively pain will be accessed by visual analogue scale . Visual analogue scale (VAS) scale has score from 0 to 10 where 0 score indicate no or minimal pain and score of 10 indicate worst possible pain.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026